Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial.

Nature medicine·2026
Same author

Prevalence of cardiac dysfunction and longitudinal changes in cardiac function after breast cancer treatment with chemotherapy with/without radiation therapy compared with controls.

Breast (Edinburgh, Scotland)·2026
Same author

Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy.

European journal of nuclear medicine and molecular imaging·2025
Same author

Cardiac [<sup>99m</sup>Tc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?

European journal of nuclear medicine and molecular imaging·2023
Same author

Correction to: Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: A systematic review.

European journal of nuclear medicine and molecular imaging·2023
Same author

Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: A systematic review.

European journal of nuclear medicine and molecular imaging·2023

Related Experiment Video

Updated: Jul 29, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

CXCR3 expression in human central nervous system diseases.

S H Goldberg1, P van der Meer, J Hesselgesser

  • 1Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Neuropathology and Applied Neurobiology
|July 5, 2001
PubMed
Summary

The CXCR3 receptor is found in astrocytes and Purkinje cells within the central nervous system (CNS). This discovery may link CXCR3 to reactive gliosis in various CNS diseases.

More Related Videos

In Vivo Imaging of Cx3cr1gfp/gfp Reporter Mice with Spectral-domain Optical Coherence Tomography and Scanning Laser Ophthalmoscopy
06:19

In Vivo Imaging of Cx3cr1gfp/gfp Reporter Mice with Spectral-domain Optical Coherence Tomography and Scanning Laser Ophthalmoscopy

Published on: November 11, 2017

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Related Experiment Videos

Last Updated: Jul 29, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

In Vivo Imaging of Cx3cr1gfp/gfp Reporter Mice with Spectral-domain Optical Coherence Tomography and Scanning Laser Ophthalmoscopy
06:19

In Vivo Imaging of Cx3cr1gfp/gfp Reporter Mice with Spectral-domain Optical Coherence Tomography and Scanning Laser Ophthalmoscopy

Published on: November 11, 2017

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • The CXCR3 chemokine receptor is present on T lymphocytes and in the CNS during inflammation.
  • The distribution of CXCR3 within parenchymal CNS cells was previously unknown.

Purpose of the Study:

  • To determine the expression pattern of CXCR3 in parenchymal cells of the central nervous system (CNS).

Main Methods:

  • Utilized a monoclonal antibody against CXCR3.
  • Examined post-mortem CNS tissue from patients with and without CNS pathology.
  • Conducted immunofluorescence studies on glial cultures.
  • Performed in situ hybridization for CXCR3 mRNA in Purkinje cells.

Main Results:

  • CXCR3 was detected in astrocytes (especially reactive astrocytes) and cerebellar Purkinje cells.
  • Expression was also found in arterial endothelial and smooth muscle cells, particularly near atherosclerotic plaques.
  • CXCR3-positive astrocytes were prominent in CNS conditions like HIV, Multiple Sclerosis (MS), ischemic infarcts, and astrocytic neoplasms.
  • CXCR3 mRNA was confirmed in Purkinje cells.

Conclusions:

  • Predominant CXCR3 expression in reactive astrocytes suggests a role in reactive gliosis across diverse CNS conditions (infectious, inflammatory, vascular, neoplastic).
  • Further research is needed to clarify the relationship between CXCR3 expression in astrocytes and its presence in Purkinje, endothelial, and smooth muscle cells.